NASDAQ:APVO - Aptevo Therapeutics Inc.
$0.89
 $0.02
+2.02%
4:00PM EDT
2019-07-22
Aptevo Therapeutics Inc. is a biotechnology company. The Company is focused on oncology and hematology therapeutics. The Company is engaged in the discovery, development, commercialization and sale of oncology and hematology therapeutics. The Company's technology is the ADAPTIR (modular protein technology) platform. The Company has approximately four products in the areas of hematology and infectious diseases, as well as various investigational-stage product candidates in immuno-oncology. The Company's investigational-stage product candidates include MOR209/ES414, ES210, ES425, Otlertuzumab and 5E3. Its technology can produce monospecific and multispecific immunotherapeutic proteins that bind to various targets. The Company's marketed products are WinRho SDF (Rho(D) Immune Globulin Intravenous (Human)), HepaGam B (Hepatitis B Immune Globulin Intravenous (Human)), VARIZIG (Varicella Zoster Immune Globulin (Human)), and IXINITY (coagulation factor IX (recombinant)). Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  APVO     avg for
industry  
  avg for
sector  
42 stocks weight:  20. 31   0. 00   0. 00  
42 stocks rank:  3. 31 K 1. 35 K 799. 74  
# analyst opinions:  3. 00   12. 76   13. 14  
mean recommendation:  1. 70   2. 11   2. 07  

quick ratio:  2. 34   5. 61   1. 85  
current ratio:  3. 15   6. 00   2. 31  

target price low:  0. 67   75. 88   108. 31  
target price avg:  1. 11   97. 27   130. 10  
target price high:  1. 20   124. 58   149. 02  
1-yr high:  5. 63   104. 89   135. 09  
last close:  0. 89   79. 79   118. 76  
50-day avg:  0. 83   79. 39   116. 18  
200-day avg:  1. 64   81. 61   114. 52  
1-yr low:  0. 70   62. 76   94. 70  
volume:  848. 03 K 2. 99 M 4. 43 M
50-day avg volume:  504. 91 K 3. 39 M 4. 22 M
200-day avg volume:  406. 77 K 3. 13 M 4. 83 M

1-day return:  2. 02 % 0. 33 % 0. 14 %
this week return:  2. 02 % 0. 33 % 0. 14 %
12-wk return:  21. 40 % 1. 00 % 3. 51 %
52-wk return:  -82. 32 % 0. 58 % 10. 25 %

enterprise value (EV):  25. 51 M 44. 78 B 115. 63 B
market cap:  40. 71 M 38. 01 B 103. 29 B
EBITDA:  -47. 22 M 4. 47 B 7. 73 B
enterprise multiple (EV/EBITDA):  -0. 54   2. 11   11. 26  
enterprise/revenue (EV/R):  0. 98   61. 53   10. 40  
total revenue:  26. 02 M 10. 43 B 31. 15 B
total debt:  23. 41 M 11. 72 B 16. 76 B
debt/equity:  59. 83   61. 22   124. 43  
net income (common):  -51. 85 M 2. 06 B 3. 79 B

shares outstanding:  22. 41 M 562. 08 M 1. 27 B
shares:  31. 48 M 573. 33 M 1. 26 B
shares short:  236. 78 K 11. 60 M 12. 29 M
shares short prior month:  313. 58 K 9. 81 M 12. 46 M
short ratio:  0. 36   5. 88   3. 41  
short % of float:  0. 62 % 6. 88 % 2. 72 %
total cash/share:  0. 82   10. 62   8. 83  
total cash:  37. 01 M 6. 17 B 5. 72 B
free cash flow:  -26. 03 M 3. 08 B 3. 10 B
operating cash flow:  -48. 29 M 3. 99 B 4. 08 B

book value:  0. 87   12. 74   26. 25  
price/book:  1. 02   4. 38   9. 01  
gross profits:  -23. 53 M 7. 93 B 35. 64 B
operating margins:  -190. 65 % -319. 65 % -29. 05 %
EBITDA margins:  -181. 48 % 11. 82 % 24. 13 %
profit margins:  -199. 30 % 5. 62 % 14. 29 %
gross margins:  -83. 53 % 34. 75 % 57. 07 %

1-yr max volatility:  39. 88 % --- ---
1-yr mean volatility:  3. 24 % 1. 95 % 1. 25 %

1-yr EPS:  -2. 17   1. 58   3. 82  
forward EPS:  -1. 01   3. 16   6. 65  
P/E:  -0. 41   0. 21   31. 97  
forward P/E:  -0. 86   4. 95   15. 14  
PE/G:  -0. 01   0. 74   0. 13  
growth:  72. 50 % 295. 81 % 85. 47 %
earnings high:  -0. 23   0. 84   1. 56  
earnings avg:  -0. 33   0. 65   1. 45  
earnings low:  -0. 48   0. 40   1. 35  
revenue high:  7. 23 M 2. 70 B 8. 76 B
revenue avg:  7. 04 M 2. 64 B 8. 62 B
revenue low:  6. 90 M 2. 58 B 8. 45 B
return on assets:  -34. 25 % -3. 43 % 4. 51 %
return on equity:  -96. 48 % -104. 30 % 140. 44 %
revenue growth:  72. 50 % 295. 25 % 78. 55 %
revenue/share:  1. 09   12. 50   51. 58  

beta (1yr vs S&P500):  1. 36   1. 27   0. 91  
sharpe (1yr):  -1. 75   0. 20   0. 80  

held % insiders:  16. 31 % 6. 63 % 3. 46 %
held % institutions:  41. 88 % 76. 45 % 67. 87 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-22 : APVO
.    100.962 =       100.962 :: --> INITIAL WEIGHT <--
.    - 2.171 =        98.791 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.152 =       212.623 :: P/E factor
.    x 2.209 =       469.675 :: PE/G factor
.    x 1.562 =        733.61 :: beta factor
.    x 0.755 =        553.68 :: sharpe factor
.    x 2.525 =      1398.117 :: current ratio factor
.    x 1.321 =      1847.268 :: quick ratio factor
.    x 1.881 =      3474.741 :: short ratio factor
.    x 1.991 =       6919.52 :: revenue growth factor
.    x 1.016 =      7029.838 :: EV/R factor
.    x 1.005 =      7065.585 :: price-to-book factor
.    x 1.111 =      7852.729 :: debt-to-revenue factor
.    x 1.406 =     11041.947 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.759 =     30467.325 :: sector+industry 1-year gains factor
.     x 1.01 =     30771.543 :: industry 12-weeks return factor
.    x 1.309 =     40291.227 :: industry 2-weeks return factor
.    x 1.228 =     49471.907 :: 5-day avg > 50-day avg
.    / 2.013 =     24578.335 :: overall "drift" factor
.    x 0.885 =     21753.614 :: largest single-day jump factor
.    x 0.061 =      1334.987 :: low price factor
.    x 0.327 =       437.141 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.    x 0.997 =       435.758 :: forward EPS factor
.    x 0.999 =       435.258 :: forward P/E factor
.    x 1.184 =       515.328 :: industry recommendation factor
.    x 2.373 =      1222.695 :: company recommendation factor
.    x 1.002 =      1224.553 :: factor historical industry gain for week 29
.    x 0.924 =      1131.796 :: target low factor
.     x 1.17 =       1323.74 :: target mean factor
.    x 1.025 =      1356.909 :: target high factor
.    x 4.715 =      6398.148 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         8.944 :: reduced for readability
.   + 11.362 =        20.306 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                     20.306 :: FINAL WEIGHT for NASDAQ:APVO


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org